Objective: To investigate clinical efficacy as well as the incidence and extent of complications regarding intrathecal baclofen (ITB) therapy in children. Methods: This is a retrospective medical chart review of three paediatric patients with acquired brain injuries (ABI) resulting from drowning who underwent ITB pump implantation for treatment of severe spasticity. Results: Compared to the pre-operative state, ITB therapy reduced spasticity with a corresponding decrease of modified Ashworth scale in upper (3.2 ± 1.4 to 1.3 ± 0.6) and lower extremities (3.5 ± 0.9 to 2.0 ± 1.0). Overall, six complications, five device-related and one accidental, were found in two out of three patients. Conclusion: Intrathecal baclofen is an effective therapy...
Objective. Intrathecal baclofen (ITB) has become the first choice in the management of deleterious s...
Objective Intrathecal baclofen treatment is used for the treatment of dystonia in patients with seve...
Introduction Increasing clinical use of Intrathecal baclofen (ITB) in Australian tertiary paediatric...
Objective: To investigate clinical efficacy and incidence of complications regarding intrathecal bac...
The purpose of this study was to investigate the incidence of complications in pediatric spastic cer...
Intrathecal baclofen (ITB) has been known to reduce spasticity which did not respond to oral medicat...
Continuous intrathecal baclofen infusion (CIBI) for spasticity of spinal and cerebral origin has bee...
Spasticity is a common presentation in a wide variety of neurological disorders like cerebral palsy ...
Background/Aim. Spasticity is the consequence of several clinical conditions including cerebral pals...
Background/Objective: Intrathecal baclofen (ITB) has been shown to be an effective treatment for sev...
Introduction: Intrathecal baclofen treatment (ITB) is widely used in children with cerebral palsy. A...
This study reports the use of intrathecal baclofen in two ventilator‐dependent children with severe ...
This case report describes an 11-year-old boy with spastic diplegia whose reflex status, range of mo...
Among features of motor disorders in children, spasticity is associated with considerable morbidity ...
Spasticity is present in 80% of children experiencing Cerebral Palsy (CP) and 50% of those having su...
Objective. Intrathecal baclofen (ITB) has become the first choice in the management of deleterious s...
Objective Intrathecal baclofen treatment is used for the treatment of dystonia in patients with seve...
Introduction Increasing clinical use of Intrathecal baclofen (ITB) in Australian tertiary paediatric...
Objective: To investigate clinical efficacy and incidence of complications regarding intrathecal bac...
The purpose of this study was to investigate the incidence of complications in pediatric spastic cer...
Intrathecal baclofen (ITB) has been known to reduce spasticity which did not respond to oral medicat...
Continuous intrathecal baclofen infusion (CIBI) for spasticity of spinal and cerebral origin has bee...
Spasticity is a common presentation in a wide variety of neurological disorders like cerebral palsy ...
Background/Aim. Spasticity is the consequence of several clinical conditions including cerebral pals...
Background/Objective: Intrathecal baclofen (ITB) has been shown to be an effective treatment for sev...
Introduction: Intrathecal baclofen treatment (ITB) is widely used in children with cerebral palsy. A...
This study reports the use of intrathecal baclofen in two ventilator‐dependent children with severe ...
This case report describes an 11-year-old boy with spastic diplegia whose reflex status, range of mo...
Among features of motor disorders in children, spasticity is associated with considerable morbidity ...
Spasticity is present in 80% of children experiencing Cerebral Palsy (CP) and 50% of those having su...
Objective. Intrathecal baclofen (ITB) has become the first choice in the management of deleterious s...
Objective Intrathecal baclofen treatment is used for the treatment of dystonia in patients with seve...
Introduction Increasing clinical use of Intrathecal baclofen (ITB) in Australian tertiary paediatric...